CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jul. 27, 2019	Jul. 28, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 25,539	$ 25,080
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	27,290	24,999
Non-cash share-based compensation	3,098	3,715
Deferred taxes	(1,883)	(1,050)
Provision to value inventories at LIFO	278	(176)
Gain on sale of property, equipment and fixtures	(102)	(150)
Changes in assets and liabilities:
Merchandise inventories	1,196	2,615
Patronage dividend receivable	29	718
Accounts payable to Wakefern	4,332	2,242
Accounts payable and accrued expenses	(2,430)	2,139
Accrued wages and benefits	1,639	810
Income taxes receivable / payable	(241)	2,377
Other assets and liabilities	(2,957)	(4,435)
Net cash provided by operating activities	55,788	58,884
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(27,988)	(35,464)
Proceeds from the sale of assets	102	150
Investment in notes receivable from Wakefern	(28,064)	(24,573)
Maturity of notes receivable from Wakefern	24,937	22,172
Investment in notes receivable related to New Markets Tax Credit financing	0	(4,835)
Acquisition of Gourmet Garage, net of cash acquired	(5,267)	0
Net cash used in investing activities	(36,280)	(42,550)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	1,007	225
Excess tax benefit related to share-based compensation	34	5
Proceeds from New Markets Tax Credit financing	0	6,860
Debt issuance costs	0	(297)
Principal payments of long-term debt	(1,576)	(944)
Dividends	(12,890)	(12,878)
Treasury stock purchases, including shares surrendered for withholding taxes	(1,070)	(632)
Net cash used in financing activities	(14,495)	(7,661)
NET INCREASE IN CASH AND CASH EQUIVALENTS	5,013	8,673
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	96,108	87,435
CASH AND CASH EQUIVALENTS, END OF YEAR	101,121	96,108
SUPPLEMENTAL DISCLOSURES OF CASH PAYMENTS MADE FOR:
Interest	4,436	4,460
Income taxes	12,074	6,420
Investment in Wakefern and increase in notes payable to Wakefern	891	0
Capital expenditures included in accounts payable and accrued expenses	$ 7,372	$ 1,233